GO TO: Recent Comment Letters
ALL |
All 10-K/Qs
Large
Mid
Small
Micro
|
Earnings Release
Proxy
|
SORT BY :
Most Recent
Company Name
| Company | Time | Size | View | Financials | Document | SEC | Period | Revenue MRQ | Assets | EPS Diluted | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| NEKTAR THERAPEUTICS (NKTR) | 8/14/2026 6:12:19 AM | Mid | View | Financials | 10-Q | SEC | 2Q 2026 ending: 6/30/2026 | Rev: $10,131,000 -9.3% | Assets $1,095,129,000 | EPS -$1.23 | |
| NEKTAR THERAPEUTICS (NKTR) | 8/13/2026 4:28:47 PM | View | Financials | Earnings | SEC | 2Q 2026 | Rev $10,131,000 -9.3% | Assets $1,095,129,000 | EPS -$1.23 | Export Earnings Model | |
| NEKTAR THERAPEUTICS (NKTR) | 5/8/2026 6:13:27 AM | Small | View | Financials | 10-Q | SEC | 1Q 2026 ending: 3/31/2026 | Rev: $10,861,000 +3.8% | Assets $763,271,000 | EPS -$1.82 | |
| NEKTAR THERAPEUTICS (NKTR) | 5/7/2026 4:49:41 PM | View | Financials | Earnings | SEC | 1Q 2026 | Rev $10,861,000 +3.8% | Assets $763,271,000 | EPS -$1.82 | Export Earnings Model | |
| NEKTAR THERAPEUTICS (NKTR) | 4/24/2026 4:38:33 PM | View | Proxy | SEC | Y 2025 | ||||||
| NEKTAR THERAPEUTICS (NKTR) | 3/13/2026 6:22:08 AM | Small | View | Financials | 10-K | SEC | Y 2025 ending: 12/31/2025 | Rev: $55,232,000 -43.9% | Assets $280,406,000 | EPS -$9.73 | |
| NEKTAR THERAPEUTICS (NKTR) | 3/12/2026 4:47:33 PM | View | Financials | Earnings | SEC | Y 2025 | Rev $21,807,000 -25.3% | Assets $280,406,000 | EPS -$1.59 | Export Earnings Model | |
| NEKTAR THERAPEUTICS (NKTR) | 11/7/2025 6:12:30 AM | Small | View | Financials | 10-Q | SEC | 3Q 2025 ending: 9/30/2025 | Rev: $11,790,000 -51.1% | Assets $301,347,000 | EPS -$1.87 | |
| NEKTAR THERAPEUTICS (NKTR) | 11/6/2025 4:33:57 PM | View | Financials | Earnings | SEC | 3Q 2025 | Rev $11,790,000 -51.1% | Assets $301,347,000 | EPS -$1.87 | Export Earnings Model | |
| NEKTAR THERAPEUTICS (NKTR) | 8/8/2025 6:13:39 AM | Small | View | Financials | 10-Q | SEC | 2Q 2025 ending: 6/30/2025 | Rev: $11,175,000 -52.4% | Assets $207,534,000 | EPS -$2.95 | |
| NEKTAR THERAPEUTICS (NKTR) | 8/7/2025 4:34:05 PM | View | Financials | Earnings | SEC | 2Q 2025 | Rev $11,175,000 -52.4% | Assets $207,534,000 | EPS -$2.95 | Export Earnings Model | |
| NEKTAR THERAPEUTICS (NKTR) | 5/9/2025 6:12:17 AM | Small | View | Financials | 10-Q | SEC | 1Q 2025 ending: 3/31/2025 | Rev: $10,460,000 -51.7% | Assets $256,241,000 | EPS -$0.24 | |
| NEKTAR THERAPEUTICS (NKTR) | 5/8/2025 4:34:01 PM | View | Financials | Earnings | SEC | 1Q 2025 | Rev $10,460,000 -51.7% | Assets $256,241,000 | EPS -$0.24 | Export Earnings Model | |
| NEKTAR THERAPEUTICS (NKTR) | 4/25/2025 4:43:43 PM | View | Proxy | SEC | Y 2024 | ||||||
| NEKTAR THERAPEUTICS (NKTR) | 3/14/2025 4:14:15 PM | Small | View | Financials | 10-K | SEC | Y 2024 ending: 12/31/2024 | Rev: $98,427,000 +9.2% | Assets $303,850,000 | EPS -$0.58 | |
| NEKTAR THERAPEUTICS (NKTR) | 3/12/2025 4:21:33 PM | View | Financials | Earnings | SEC | Y 2024 | Rev $29,175,000 +22.1% | Assets $303,850,000 | EPS $0.04 | Export Earnings Model | |
| NEKTAR THERAPEUTICS (NKTR) | 11/8/2024 6:12:01 AM | Small | View | Financials | 10-Q | SEC | 3Q 2024 ending: 9/30/2024 | Rev: $24,124,000 -0.1% | Assets $307,966,000 | EPS -$0.18 | |
| NEKTAR THERAPEUTICS (NKTR) | 11/7/2024 4:48:06 PM | View | Financials | Earnings | SEC | 3Q 2024 | Rev $24,124,000 -0.1% | Assets $307,966,000 | EPS -$0.18 | Export Earnings Model | |
| NEKTAR THERAPEUTICS (NKTR) | 8/9/2024 6:15:28 AM | Small | View | Financials | 10-Q | SEC | 2Q 2024 ending: 6/30/2024 | Rev: $23,489,000 +14.6% | Assets $343,334,000 | EPS -$0.25 | |
| NEKTAR THERAPEUTICS (NKTR) | 8/8/2024 4:36:19 PM | View | Financials | Earnings | SEC | 2Q 2024 | Rev $23,489,000 +14.6% | Assets $343,334,000 | EPS -$0.25 | Export Earnings Model | |
| NEKTAR THERAPEUTICS (NKTR) | 5/10/2024 6:19:31 AM | Small | View | Financials | 10-Q | SEC | 1Q 2024 ending: 3/31/2024 | Rev: $21,639,000 +0.2% | Assets $396,012,000 | EPS -$0.19 | |
| NEKTAR THERAPEUTICS (NKTR) | 5/9/2024 4:26:07 PM | View | Financials | Earnings | SEC | 1Q 2024 | Rev $21,639,000 +0.2% | Assets $396,012,000 | EPS -$0.19 | Export Earnings Model | |
| NEKTAR THERAPEUTICS (NKTR) | 4/26/2024 4:29:03 PM | View | Proxy | SEC | Y 2023 | ||||||
| NEKTAR THERAPEUTICS (NKTR) | 3/5/2024 5:26:05 PM | Small | View | Financials | 10-K | SEC | Y 2023 ending: 12/31/2023 | Rev: $90,122,000 -2.1% | Assets $398,033,000 | EPS -$1.45 | |
| NEKTAR THERAPEUTICS (NKTR) | 3/4/2024 4:21:42 PM | View | Financials | Earnings | SEC | Y 2023 | Rev $23,885,000 +8.5% | Assets $398,033,000 | EPS -$0.22 | Export Earnings Model | |
| NEKTAR THERAPEUTICS (NKTR) | 1/10/2024 4:26:43 PM | View | Financials | Earnings (Prelim) | SEC | Y 2023 | Export Earnings Model | ||||
| NEKTAR THERAPEUTICS (NKTR) | 11/8/2023 6:16:06 AM | Small | View | Financials | 10-Q | SEC | 3Q 2023 ending: 9/30/2023 | Rev: $24,144,000 +2.2% | Assets $442,244,000 | EPS -$0.24 | |
| NEKTAR THERAPEUTICS (NKTR) | 11/7/2023 4:29:48 PM | View | Financials | Earnings | SEC | 3Q 2023 | Rev $24,144,000 +2.2% | Assets $442,244,000 | EPS -$0.24 | Export Earnings Model | |
| NEKTAR THERAPEUTICS (NKTR) | 8/9/2023 6:15:14 AM | Small | View | Financials | 10-Q | SEC | 2Q 2023 ending: 6/30/2023 | Rev: $20,499,000 -5.0% | Assets $494,279,000 | EPS -$0.27 | |
| NEKTAR THERAPEUTICS (NKTR) | 8/8/2023 4:38:50 PM | View | Financials | Earnings | SEC | 2Q 2023 | Rev $20,499,000 -5.0% | Assets $494,279,000 | EPS -$0.27 | Export Earnings Model | |
| NEKTAR THERAPEUTICS (NKTR) | 5/10/2023 6:12:55 AM | Small | View | Financials | 10-Q | SEC | 1Q 2023 ending: 3/31/2023 | Rev: $21,594,000 -13.0% | Assets $561,743,000 | EPS -$0.73 | |
| NEKTAR THERAPEUTICS (NKTR) | 5/9/2023 4:38:23 PM | View | Financials | Earnings | SEC | 1Q 2023 | Rev $21,594,000 -13.0% | Assets $561,743,000 | EPS -$0.73 | Export Earnings Model | |
| NEKTAR THERAPEUTICS (NKTR) | 4/28/2023 4:33:23 PM | View | Proxy | SEC | Y 2022 | ||||||
| NEKTAR THERAPEUTICS (NKTR) | 2/28/2023 5:32:41 PM | View | Financials | Earnings | SEC | Y 2022 | Rev $22,023,000 -11.9% | Assets $710,600,000 | EPS -$0.32 | Export Earnings Model | |
| NEKTAR THERAPEUTICS (NKTR) | 2/28/2023 5:21:35 PM | Small | View | Financials | 10-K | SEC | Y 2022 ending: 12/31/2022 | Rev: $92,055,000 -9.7% | Assets $710,600,000 | EPS -$1.97 | |
| NEKTAR THERAPEUTICS (NKTR) | 1/9/2023 9:01:51 AM | View | Financials | Earnings (Prelim) | SEC | Y 2022 | Export Earnings Model | ||||
| NEKTAR THERAPEUTICS (NKTR) | 11/4/2022 3:28:34 PM | Small | View | Financials | 10-Q | SEC | 3Q 2022 ending: 9/30/2022 | Rev: $23,625,000 -5.2% | Assets $781,006,000 | EPS -$0.31 | |
| NEKTAR THERAPEUTICS (NKTR) | 11/3/2022 4:44:12 PM | View | Financials | Earnings | SEC | 3Q 2022 | Rev $23,625,000 -5.2% | Assets $781,006,000 | EPS -$0.31 | Export Earnings Model | |
| NEKTAR THERAPEUTICS (NKTR) | 8/5/2022 6:16:48 AM | Mid | View | Financials | 10-Q | SEC | 2Q 2022 ending: 6/30/2022 | Rev: $21,585,000 -23.8% | Assets $861,987,000 | EPS -$0.85 | |
| NEKTAR THERAPEUTICS (NKTR) | 8/4/2022 4:28:44 PM | View | Financials | Earnings | SEC | 2Q 2022 | Rev $21,585,000 -23.8% | Assets $861,987,000 | EPS -$0.85 | Export Earnings Model | |
| NEKTAR THERAPEUTICS (NKTR) | 5/6/2022 6:18:31 AM | Mid | View | Financials | 10-Q | SEC | 1Q 2022 ending: 3/31/2022 | Rev: $24,822,000 +5.0% | Assets $1,024,116,000 | EPS -$0.49 | |
| Nektar Therapeutics (NKTR) | 5/5/2022 4:22:29 PM | View | Financials | Earnings | WIRE | 1Q 2022 | Rev $24,822,000 +5.0% | Assets $1,024,116,000 | EPS -$0.49 | Export Earnings Model | |
| NEKTAR THERAPEUTICS (NKTR) | 4/29/2022 9:06:34 AM | View | Proxy | SEC | Y 2021 | ||||||
| NEKTAR THERAPEUTICS (NKTR) | 4/25/2022 4:41:57 PM | View | Financials | Earnings (Prelim) | SEC | 1Q 2022 | Export Earnings Model | ||||
| NEKTAR THERAPEUTICS (NKTR) | 3/1/2022 6:31:21 AM | Mid | View | Financials | 10-K | SEC | Y 2021 ending: 12/31/2021 | Rev: $101,907,000 -33.4% | Assets $1,117,189,000 | EPS -$2.86 | |
| NEKTAR THERAPEUTICS (NKTR) | 2/28/2022 4:52:28 PM | View | Financials | Earnings | SEC | Y 2021 | Rev $25,009,000 +6.6% | Assets $1,117,189,000 | EPS -$0.79 | Export Earnings Model | |
| NEKTAR THERAPEUTICS (NKTR) | 1/11/2022 11:32:11 AM | View | Financials | Earnings (Prelim) | SEC | Y 2021 | Export Earnings Model | ||||
| NEKTAR THERAPEUTICS (NKTR) | 11/5/2021 6:23:11 AM | Mid | View | Financials | 10-Q | SEC | 3Q 2021 ending: 9/30/2021 | Rev: $24,921,000 -17.0% | Assets $1,277,243,000 | EPS -$0.70 | |
| NEKTAR THERAPEUTICS (NKTR) | 11/4/2021 4:32:36 PM | View | Financials | Earnings | SEC | 3Q 2021 | Rev $24,921,000 -17.0% | Assets $1,277,243,000 | EPS -$0.70 | Export Earnings Model | |
| NEKTAR THERAPEUTICS (NKTR) | 8/6/2021 6:12:03 AM | Mid | View | Financials | 10-Q | SEC | 2Q 2021 ending: 6/30/2021 | Rev: $28,330,000 -42.0% | Assets $1,371,351,000 | EPS -$0.69 | |
| NEKTAR THERAPEUTICS (NKTR) | 8/5/2021 4:27:54 PM | View | Financials | Earnings | SEC | 2Q 2021 | Rev $28,330,000 -42.0% | Assets $1,371,351,000 | EPS -$0.69 | Export Earnings Model | |
| NEKTAR THERAPEUTICS (NKTR) | 5/7/2021 6:11:49 AM | Mid | View | Financials | 10-Q | SEC | 1Q 2021 ending: 3/31/2021 | Rev: $23,647,000 -53.2% | Assets $1,456,561,000 | EPS -$0.68 | |
| NEKTAR THERAPEUTICS (NKTR) | 5/6/2021 4:27:05 PM | View | Financials | Earnings | SEC | 1Q 2021 | Rev $23,647,000 -53.2% | Assets $1,456,561,000 | EPS -$0.68 | Export Earnings Model | |
| NEKTAR THERAPEUTICS (NKTR) | 4/30/2021 12:28:08 PM | View | Proxy | SEC | Y 2020 | ||||||
| NEKTAR THERAPEUTICS (NKTR) | 2/26/2021 6:25:14 AM | Mid | View | Financials | 10-K | SEC | Y 2020 ending: 12/31/2020 | Rev: $152,915,000 +33.4% | Assets $1,538,767,000 | EPS -$2.49 | |
| NEKTAR THERAPEUTICS (NKTR) | 2/25/2021 4:35:33 PM | View | Financials | Earnings | SEC | Y 2020 | Rev $23,462,000 -30.7% | Assets $1,538,767,000 | EPS -$0.65 | Export Earnings Model | |
| NEKTAR THERAPEUTICS (NKTR) | 1/11/2021 7:01:28 AM | View | Financials | Earnings (Prelim) | SEC | Y 2020 | Export Earnings Model | ||||
| NEKTAR THERAPEUTICS (NKTR) | 11/6/2020 6:14:46 AM | Mid | View | Financials | 10-Q | SEC | 3Q 2020 ending: 9/30/2020 | Rev: $30,033,000 +2.8% | Assets $1,508,666,000 | EPS -$0.61 | |
| NEKTAR THERAPEUTICS (NKTR) | 11/5/2020 4:45:20 PM | View | Financials | Earnings | SEC | 3Q 2020 | Rev $30,033,000 +2.8% | Assets $1,508,666,000 | EPS -$0.61 | Export Earnings Model | |
| NEKTAR THERAPEUTICS (NKTR) | 8/7/2020 6:22:22 AM | Mid | View | Financials | 10-Q | SEC | 2Q 2020 ending: 6/30/2020 | Rev: $48,847,000 +109.5% | Assets $1,594,878,000 | EPS -$0.45 | |
| NEKTAR THERAPEUTICS (NKTR) | 8/6/2020 4:23:22 PM | View | Financials | Earnings | SEC | 2Q 2020 | Rev $48,847,000 +109.5% | Assets $1,594,878,000 | EPS -$0.45 | Export Earnings Model | |
| NEKTAR THERAPEUTICS (NKTR) | 5/8/2020 6:24:34 AM | Mid | View | Financials | 10-Q | SEC | 1Q 2020 ending: 3/31/2020 | Rev: $50,573,000 +79.2% | Assets $1,887,933,000 | EPS -$0.78 | |
| NEKTAR THERAPEUTICS (NKTR) | 5/7/2020 4:40:21 PM | View | Financials | Earnings | SEC | 1Q 2020 | Rev $50,573,000 +79.2% | Assets $1,887,933,000 | EPS -$0.78 | Export Earnings Model | |
| NEKTAR THERAPEUTICS (NKTR) | 4/29/2020 4:50:34 PM | View | Proxy | SEC | Y 2019 | ||||||
| NEKTAR THERAPEUTICS (NKTR) | 2/28/2020 6:34:27 AM | Mid | View | Financials | 10-K | SEC | Y 2019 ending: 12/31/2019 | Rev: $114,617,000 -90.4% | Assets $1,977,356,000 | EPS -$2.52 | |
| NEKTAR THERAPEUTICS (NKTR) | 2/27/2020 4:57:25 PM | View | Financials | Earnings | SEC | Y 2019 | Rev $33,862,000 -15.0% | Assets $1,977,356,000 | EPS -$0.64 | Export Earnings Model | |
| NEKTAR THERAPEUTICS (NKTR) | 11/7/2019 6:49:55 AM | Mid | View | Financials | 10-Q | SEC | 3Q 2019 ending: 9/30/2019 | Rev: $29,218,000 +5.2% | Assets $2,088,294,000 | EPS -$0.56 | |
| NEKTAR THERAPEUTICS (NKTR) | 11/6/2019 4:40:26 PM | View | Financials | Earnings | SEC | 3Q 2019 | Rev $29,218,000 +5.2% | Assets $2,088,294,000 | EPS -$0.56 | Export Earnings Model | |
| NEKTAR THERAPEUTICS (NKTR) | 8/9/2019 6:12:33 AM | Mid | View | Financials | 10-Q | SEC | 2Q 2019 ending: 6/30/2019 | Rev: $23,315,000 -97.9% | Assets $2,099,653,000 | EPS -$0.63 | |
| NEKTAR THERAPEUTICS (NKTR) | 8/8/2019 4:51:25 PM | View | Financials | Earnings | SEC | 2Q 2019 | Rev $23,315,000 -97.9% | Assets $2,099,653,000 | EPS -$0.63 | Export Earnings Model | |
| NEKTAR THERAPEUTICS (NKTR) | 5/9/2019 6:16:00 AM | Mid | View | Financials | 10-Q | SEC | 1Q 2019 ending: 3/31/2019 | Rev: $28,222,000 -25.8% | Assets $2,166,482,000 | EPS -$0.69 | |
| NEKTAR THERAPEUTICS (NKTR) | 5/8/2019 4:21:51 PM | View | Financials | Earnings | SEC | 1Q 2019 | Rev $28,222,000 -25.8% | Assets $2,166,482,000 | EPS -$0.69 | Export Earnings Model | |
| NEKTAR THERAPEUTICS (NKTR) | 4/30/2019 4:54:52 PM | View | Proxy | SEC | Y 2018 | ||||||
| NEKTAR THERAPEUTICS (NKTR) | 3/1/2019 6:40:13 AM | Mid | View | Financials | 10-K | SEC | Y 2018 ending: 12/31/2018 | Rev: $1,193,323,000 +287.8% | Assets $2,150,172,000 | EPS $3.78 | |
| Nektar Therapeutics (NKTR) | 2/28/2019 4:23:03 PM | View | Financials | Earnings | WIRE | Y 2018 | Rev $39,826,000 -58.3% | Assets $2,150,172,000 | EPS -$0.57 | Export Earnings Model | |
| NEKTAR THERAPEUTICS (NKTR) | 1/8/2019 11:32:48 AM | View | Financials | Earnings (Prelim) | SEC | Y 2018 | Export Earnings Model | ||||
| NEKTAR THERAPEUTICS (NKTR) | 11/8/2018 6:27:29 AM | Mid | View | Financials | 10-Q | SEC | 3Q 2018 ending: 9/30/2018 | Rev: $27,762,000 -81.8% | Assets $2,249,098,000 | EPS -$0.56 | |
| NEKTAR THERAPEUTICS (NKTR) | 11/7/2018 4:44:45 PM | View | Financials | Earnings | SEC | 3Q 2018 | Rev $27,762,000 -81.8% | Assets $2,249,098,000 | EPS -$0.56 | Export Earnings Model | |
| NEKTAR THERAPEUTICS (NKTR) | 8/9/2018 6:23:50 AM | Mid | View | Financials | 10-Q | SEC | 2Q 2018 ending: 6/30/2018 | Rev: $1,087,717,000 +3,044.7% | Assets $2,313,087,000 | EPS $5.33 | |
| NEKTAR THERAPEUTICS (NKTR) | 8/8/2018 4:30:13 PM | View | Financials | Earnings | SEC | 2Q 2018 | Rev $1,087,717,000 +3,044.7% | Assets $2,313,087,000 | EPS $5.33 | Export Earnings Model | |
| NEKTAR THERAPEUTICS (NKTR) | 5/10/2018 5:17:50 PM | View | Financials | Earnings | SEC | 1Q 2018 | Rev $38,018,000 +53.7% | Assets $496,790,000 | EPS -$0.60 | Export Earnings Model | |
| NEKTAR THERAPEUTICS (NKTR) | 5/10/2018 5:00:08 PM | Small | View | Financials | 10-Q | SEC | 1Q 2018 ending: 3/31/2018 | Rev: $38,018,000 +53.7% | Assets $496,790,000 | EPS -$0.60 | |
| NEKTAR THERAPEUTICS (NKTR) | 4/30/2018 3:06:33 PM | View | Proxy | SEC | Y 2017 | ||||||
| NEKTAR THERAPEUTICS (NKTR) | 3/1/2018 5:22:32 PM | Small | View | Financials | 10-K | SEC | Y 2017 ending: 12/31/2017 | Rev: $307,711,000 +86.0% | Assets $508,866,000 | EPS -$0.62 | |
| Nektar Therapeutics (NKTR) | 3/1/2018 4:26:34 PM | View | Financials | Earnings | SEC | Y 2017 | Rev $95,466,000 +154.9% | Assets $508,866,000 | EPS -$0.21 | Export Earnings Model | |
| NEKTAR THERAPEUTICS (NKTR) | 11/8/2017 6:15:34 AM | Small | View | Financials | 10-Q | SEC | 3Q 2017 ending: 9/30/2017 | Rev: $152,928,000 +320.9% | Assets $582,055,000 | EPS $0.37 | |
| NEKTAR THERAPEUTICS (NKTR) | 11/7/2017 4:50:47 PM | View | Financials | Earnings | SEC | 3Q 2017 | Rev $152,928,000 +320.9% | Assets $582,055,000 | EPS $0.37 | Export Earnings Model | |
| NEKTAR THERAPEUTICS (NKTR) | 8/9/2017 6:12:31 AM | Small | View | Financials | 10-Q | SEC | 2Q 2017 ending: 6/30/2017 | Rev: $34,589,000 +5.6% | Assets $475,859,000 | EPS -$0.39 | |
| NEKTAR THERAPEUTICS (NKTR) | 8/8/2017 4:50:02 PM | View | Financials | Earnings | SEC | 2Q 2017 | Rev $34,589,000 +5.6% | Assets $475,859,000 | EPS -$0.39 | Export Earnings Model | |
| NEKTAR THERAPEUTICS (NKTR) | 5/10/2017 6:16:41 AM | Small | View | Financials | 10-Q | SEC | 1Q 2017 ending: 3/31/2017 | Rev: $24,728,000 -58.0% | Assets $528,486,000 | EPS -$0.42 | |
| NEKTAR THERAPEUTICS (NKTR) | 5/9/2017 4:32:05 PM | View | Financials | Earnings | SEC | 1Q 2017 | Rev $24,728,000 -58.0% | Assets $528,486,000 | EPS -$0.42 | Export Earnings Model | |
| NEKTAR THERAPEUTICS (NKTR) | 5/1/2017 3:36:09 PM | View | Proxy | SEC | Y 2016 | ||||||
| NEKTAR THERAPEUTICS (NKTR) | 3/1/2017 4:34:06 PM | View | Financials | Earnings | SEC | Y 2016 | Rev $37,452,000 -4.9% | Assets $568,871,000 | EPS -$0.28 | Export Earnings Model | |
| NEKTAR THERAPEUTICS (NKTR) | 3/1/2017 3:03:00 PM | Small | View | Financials | 10-K | SEC | Y 2016 ending: 12/31/2016 | Rev: $165,436,000 -28.3% | Assets $568,871,000 | EPS -$1.10 | |
| NEKTAR THERAPEUTICS (NKTR) | 1/10/2017 4:30:18 PM | View | Financials | Earnings | SEC | Y 2016 | Rev $37,452,000 -4.9% | Assets $568,871,000 | EPS -$0.28 | Export Earnings Model | |
| NEKTAR THERAPEUTICS (NKTR) | 11/4/2016 5:30:00 AM | Small | View | Financials | 10-Q | SEC | 3Q 2016 ending: 9/30/2016 | Rev: $36,336,000 -39.4% | Assets $425,095,000 | EPS -$0.32 | |
| NEKTAR THERAPEUTICS (NKTR) | 11/3/2016 4:33:05 PM | View | Financials | Earnings | SEC | 3Q 2016 | Rev $36,336,000 -39.4% | Assets $425,095,000 | EPS -$0.32 | Export Earnings Model | |
| NEKTAR THERAPEUTICS (NKTR) | 8/4/2016 3:33:13 PM | Small | View | Financials | 10-Q | SEC | 2Q 2016 ending: 6/30/2016 | Rev: $32,768,000 +44.6% | Assets $463,099,000 | EPS -$0.36 | |
| NEKTAR THERAPEUTICS (NKTR) | 8/3/2016 4:54:25 PM | View | Financials | Earnings | SEC | 2Q 2016 | Rev $32,768,000 +44.6% | Assets $463,099,000 | EPS -$0.36 | Export Earnings Model | |
| NEKTAR THERAPEUTICS (NKTR) | 5/4/2016 4:22:48 PM | Small | View | Financials | 10-Q | SEC | 1Q 2016 ending: 3/31/2016 | Rev: $58,882,000 -45.9% | Assets $491,879,000 | EPS -$0.14 | |
| NEKTAR THERAPEUTICS (NKTR) | 5/3/2016 4:12:40 PM | View | Financials | Earnings | SEC | 1Q 2016 | Rev $58,882,000 -45.9% | Assets $491,879,000 | EPS -$0.14 | Export Earnings Model | |
| NEKTAR THERAPEUTICS (NKTR) | 4/29/2016 1:01:11 PM | View | Proxy | SEC | Y 2015 | ||||||
| NEKTAR THERAPEUTICS (NKTR) | 3/1/2016 4:44:09 PM | View | Financials | Earnings | SEC | Y 2015 | Rev $39,370,000 +101.4% | Assets $498,642,000 | EPS -$0.40 | Export Earnings Model | |
| NEKTAR THERAPEUTICS (NKTR) | 3/1/2016 5:30:00 AM | Small | View | Financials | 10-K | SEC | Y 2015 ending: 12/31/2015 | Rev: $230,784,000 +15.0% | Assets $498,642,000 | EPS -$0.61 | |
| NEKTAR THERAPEUTICS (NKTR) | 11/6/2015 5:30:00 AM | Small | View | Financials | 10-Q | SEC | 3Q 2015 ending: 9/30/2015 | Rev: $59,952,000 -54.9% | Assets $449,246,000 | EPS -$0.06 | |
| NEKTAR THERAPEUTICS (NKTR) | 11/5/2015 4:42:29 PM | View | Financials | Earnings | SEC | 3Q 2015 | Rev $59,952,000 -54.9% | Assets $449,246,000 | EPS -$0.06 | Export Earnings Model | |
| NEKTAR THERAPEUTICS (NKTR) | 8/6/2015 5:30:00 AM | Small | View | Financials | 10-Q | SEC | 2Q 2015 ending: 6/30/2015 | Rev: $22,661,000 -20.5% | Assets $456,667,000 | EPS -$0.40 | |
| NEKTAR THERAPEUTICS (NKTR) | 8/5/2015 4:39:00 PM | View | Financials | Earnings | SEC | 2Q 2015 | Rev $22,661,000 -20.5% | Assets $456,667,000 | EPS -$0.40 | Export Earnings Model | |
| NEKTAR THERAPEUTICS (NKTR) | 5/1/2015 5:30:00 AM | Small | View | Financials | 10-Q | SEC | 1Q 2015 ending: 3/31/2015 | Rev: $108,801,000 +450.3% | Assets $499,212,000 | EPS $0.25 | |
| NEKTAR THERAPEUTICS (NKTR) | 4/30/2015 5:01:22 PM | View | Proxy | SEC | Y 2014 | ||||||
| NEKTAR THERAPEUTICS (NKTR) | 4/30/2015 4:53:06 PM | View | Financials | Earnings | SEC | 1Q 2015 | Rev $108,801,000 +450.3% | Assets $499,212,000 | EPS $0.25 | Export Earnings Model | |
| NEKTAR THERAPEUTICS (NKTR) | 2/26/2015 5:30:00 AM | Small | View | Financials | 10-K | SEC | Y 2014 ending: 12/31/2014 | Rev: $200,707,000 +34.8% | Assets $441,621,000 | EPS -$0.42 | |
| NEKTAR THERAPEUTICS (NKTR) | 2/24/2015 4:49:49 PM | View | Financials | Earnings | SEC | Y 2014 | Rev $19,551,000 -37.2% | Assets $441,621,000 | EPS -$0.35 | Export Earnings Model | |
| NEKTAR THERAPEUTICS (NKTR) | 1/13/2015 1:00:20 PM | View | Financials | Earnings | SEC | Y 2014 | Rev $19,551,000 -37.2% | Assets $441,621,000 | EPS -$0.35 | Export Earnings Model | |
| NEKTAR THERAPEUTICS (NKTR) | 11/7/2014 6:07:13 AM | Small | View | Financials | 10-Q | SEC | 3Q 2014 ending: 9/30/2014 | Rev: $132,871,000 +118.1% | Assets $476,902,000 | EPS $0.53 | |
| NEKTAR THERAPEUTICS (NKTR) | 11/6/2014 4:19:48 PM | View | Financials | Earnings | SEC | 3Q 2014 | Rev $132,871,000 +118.1% | Assets $476,902,000 | EPS $0.53 | Export Earnings Model | |
| NEKTAR THERAPEUTICS (NKTR) | 8/1/2014 5:30:00 AM | Small | View | Financials | 10-Q | SEC | 2Q 2014 ending: 6/30/2014 | Rev: $28,513,000 -15.8% | Assets $478,137,000 | EPS -$0.26 | |
| NEKTAR THERAPEUTICS (NKTR) | 7/31/2014 4:35:03 PM | View | Financials | Earnings | SEC | 2Q 2014 | Rev $28,513,000 -15.8% | Assets $478,137,000 | EPS -$0.26 | Export Earnings Model | |
| NEKTAR THERAPEUTICS (NKTR) | 5/8/2014 5:30:00 AM | Small | View | Financials | 10-Q | SEC | 1Q 2014 ending: 3/31/2014 | Rev: $19,771,000 -14.1% | Assets $487,013,000 | EPS -$0.37 | |
| NEKTAR THERAPEUTICS (NKTR) | 5/7/2014 4:28:58 PM | View | Financials | Earnings | SEC | 1Q 2014 | Rev $19,771,000 -14.1% | Assets $487,013,000 | EPS -$0.37 | Export Earnings Model | |
| NEKTAR THERAPEUTICS (NKTR) | 4/30/2014 4:11:40 PM | View | Proxy | SEC | Y 2013 | ||||||
| NEKTAR THERAPEUTICS (NKTR) | 2/27/2014 4:26:07 PM | Small | View | Financials | 10-K | SEC | Y 2013 ending: 12/31/2013 | Rev: $148,921,000 +83.4% | Assets $434,527,000 | EPS -$1.40 | |
| NEKTAR THERAPEUTICS (NKTR) | 2/26/2014 4:20:24 PM | View | Financials | Earnings | SEC | Y 2013 | Rev $31,146,000 +47.3% | Assets $434,527,000 | EPS -$0.41 | Export Earnings Model | |
| NEKTAR THERAPEUTICS (NKTR) | 1/21/2014 4:15:06 PM | View | Financials | Earnings | SEC | Y 2013 | Rev $31,146,000 +47.3% | Assets $434,527,000 | EPS -$0.41 | Export Earnings Model | |
| NEKTAR THERAPEUTICS (NKTR) | 11/7/2013 5:07:11 PM | Small | View | Financials | 10-Q | SEC | 3Q 2013 ending: 9/30/2013 | Rev: $60,909,000 +230.8% | Assets $383,035,000 | EPS -$0.14 | |
| NEKTAR THERAPEUTICS (NKTR) | 11/7/2013 4:25:30 PM | View | Financials | Earnings | SEC | 3Q 2013 | Rev $60,909,000 +230.8% | Assets $383,035,000 | EPS -$0.14 | Export Earnings Model | |
| NEKTAR THERAPEUTICS (NKTR) | 8/9/2013 3:35:12 PM | Small | View | Financials | 10-Q | SEC | 2Q 2013 ending: 6/30/2013 | Rev: $33,862,000 +43.0% | Assets $412,809,000 | EPS -$0.37 | |
| NEKTAR THERAPEUTICS (NKTR) | 8/8/2013 5:00:17 PM | View | Financials | Earnings | SEC | 2Q 2013 | Rev $33,862,000 +43.0% | Assets $412,809,000 | EPS -$0.37 | Export Earnings Model | |
| NEKTAR THERAPEUTICS (NKTR) | 5/9/2013 4:50:52 PM | View | Financials | Earnings | SEC | 1Q 2013 | Rev $23,004,000 +28.2% | Assets $447,901,000 | EPS -$0.48 | Export Earnings Model | |
| NEKTAR THERAPEUTICS (NKTR) | 5/9/2013 4:46:19 PM | Small | View | Financials | 10-Q | SEC | 1Q 2013 ending: 3/31/2013 | Rev: $23,004,000 +28.2% | Assets $447,901,000 | EPS -$0.48 | |
| NEKTAR THERAPEUTICS (NKTR) | 4/30/2013 4:05:43 PM | View | Proxy | SEC | Y 2012 | ||||||
| NEKTAR THERAPEUTICS (NKTR) | 3/1/2013 5:30:00 AM | Small | View | Financials | 10-K | SEC | Y 2012 ending: 12/31/2012 | Rev: $81,191,000 +13.6% | Assets $497,790,000 | EPS -$1.50 | |
| NEKTAR THERAPEUTICS (NKTR) | 2/28/2013 4:17:50 PM | View | Financials | Earnings | SEC | Y 2012 | Rev $21,146,000 +34.0% | Assets $497,790,000 | EPS -$0.46 | Export Earnings Model | |
| NEKTAR THERAPEUTICS (NKTR) | 11/9/2012 3:57:13 PM | Small | View | Financials | 10-Q | SEC | 3Q 2012 ending: 9/30/2012 | Rev: $18,412,000 -32.0% | Assets $541,452,000 | EPS -$0.38 | |
| NEKTAR THERAPEUTICS (NKTR) | 8/9/2012 4:31:22 PM | Small | View | Financials | 10-Q | SEC | 2Q 2012 ending: 6/30/2012 | Rev: $23,684,000 +36.7% | Assets $668,443,000 | EPS -$0.30 | |
| NEKTAR THERAPEUTICS (NKTR) | 8/9/2012 4:28:19 PM | View | Financials | Earnings | SEC | 2Q 2012 | Rev $23,684,000 +36.7% | Assets $668,443,000 | EPS -$0.30 | Export Earnings Model | |
| NEKTAR THERAPEUTICS (NKTR) | 5/4/2012 5:30:00 AM | Small | View | Financials | 10-Q | SEC | 1Q 2012 ending: 3/31/2012 | Rev: $17,949,000 +58.9% | Assets $694,789,000 | EPS -$0.36 | |
| NEKTAR THERAPEUTICS (NKTR) | 5/2/2012 5:11:39 PM | View | Financials | Earnings | SEC | 1Q 2012 | Rev $17,949,000 +58.9% | Assets $694,789,000 | EPS -$0.36 | Export Earnings Model | |
| NEKTAR THERAPEUTICS (NKTR) | 4/30/2012 5:24:25 PM | View | Proxy | SEC | Y 2011 | ||||||
| NEKTAR THERAPEUTICS (NKTR) | 2/29/2012 4:50:35 PM | Small | View | Financials | 10-K | SEC | Y 2011 ending: 12/31/2011 | Rev: $71,480,000 -55.1% | Assets $606,550,000 | EPS -$1.19 | |
| NEKTAR THERAPEUTICS (NKTR) | 2/29/2012 4:21:24 PM | View | Financials | Earnings | SEC | Y 2011 | Rev $15,782,000 -65.2% | Assets $606,550,000 | EPS -$0.33 | Export Earnings Model | |
| NEKTAR THERAPEUTICS (NKTR) | 11/4/2011 5:30:00 AM | Small | View | Financials | 10-Q | SEC | 3Q 2011 ending: 9/30/2011 | Rev: $27,068,000 -28.6% | Assets $648,093,000 | EPS -$0.21 | |
| NEKTAR THERAPEUTICS (NKTR) | 11/2/2011 4:20:48 PM | View | Financials | Earnings | SEC | 3Q 2011 | Rev $27,068,000 -28.6% | Assets $648,093,000 | EPS -$0.21 | Export Earnings Model | |
| NEKTAR THERAPEUTICS (NKTR) | 8/5/2011 4:34:07 PM | Small | View | Financials | 10-Q | SEC | 2Q 2011 ending: 6/30/2011 | Rev: $17,331,000 -59.3% | Assets $670,854,000 | EPS -$0.32 | |
| NEKTAR THERAPEUTICS (NKTR) | 8/4/2011 4:32:51 PM | View | Financials | Earnings | SEC | 2Q 2011 | Rev $17,331,000 -59.3% | Assets $670,854,000 | EPS -$0.32 | Export Earnings Model | |
| NEKTAR THERAPEUTICS (NKTR) | 4/29/2011 4:05:15 PM | Small | View | Financials | 10-Q | SEC | 1Q 2011 ending: 3/31/2011 | Rev: $11,299,000 -66.0% | Assets $704,478,000 | EPS -$0.33 | |
| NEKTAR THERAPEUTICS (NKTR) | 4/29/2011 1:15:10 PM | View | Proxy | SEC | Y 2010 | ||||||
| NEKTAR THERAPEUTICS (NKTR) | 4/27/2011 4:24:03 PM | View | Financials | Earnings | SEC | 1Q 2011 | Rev $11,299,000 -66.0% | Assets $704,478,000 | EPS -$0.33 | Export Earnings Model | |
| NEKTAR THERAPEUTICS (NKTR) | 3/1/2011 4:31:57 PM | View | Financials | Earnings | SEC | Y 2010 | Rev $45,314,000 | Assets $521,225,000 | EPS -$0.24 | Export Earnings Model | |
| NEKTAR THERAPEUTICS (NKTR) | 11/4/2010 12:00:00 AM | View | Financials | Earnings | SEC | 3Q 2010 | Rev $37,925,000 | Export Earnings Model | |||
| NEKTAR THERAPEUTICS (NKTR) | 7/28/2010 12:00:00 AM | View | Financials | Earnings | SEC | 2Q 2010 | Rev $42,563,000 | Export Earnings Model | |||
| NEKTAR THERAPEUTICS (NKTR) | 6/9/2010 12:00:00 AM | View | Financials | Earnings | SEC | 1Q 2010 | Rev $33,237,000 | Export Earnings Model | |||
| NEKTAR THERAPEUTICS (NKTR) | 6/7/2010 12:00:00 AM | View | Financials | Earnings | SEC | 1Q 2010 | Rev $33,237,000 | Export Earnings Model | |||
| NEKTAR THERAPEUTICS (NKTR) | 5/5/2010 12:00:00 AM | View | Financials | Earnings | SEC | 1Q 2010 | Rev $33,237,000 | Export Earnings Model | |||
| NEKTAR THERAPEUTICS (NKTR) | 4/30/2010 4:52:29 PM | View | Proxy | SEC | Y 2009 | ||||||
| NEKTAR THERAPEUTICS (NKTR) | 3/2/2010 12:00:00 AM | View | Financials | Earnings | SEC | Y 2009 | Export Earnings Model | ||||
| NEKTAR THERAPEUTICS (NKTR) | 11/4/2009 12:00:00 AM | View | Financials | Earnings | SEC | 3Q 2009 | Export Earnings Model | ||||
| NEKTAR THERAPEUTICS (NKTR) | 8/4/2009 12:00:00 AM | View | Financials | Earnings | SEC | 2Q 2009 | Export Earnings Model | ||||
| NEKTAR THERAPEUTICS (NKTR) | 5/6/2009 12:00:00 AM | View | Financials | Earnings | SEC | 1Q 2009 | Export Earnings Model | ||||
| NEKTAR THERAPEUTICS (NKTR) | 4/29/2009 6:00:52 AM | View | Proxy | SEC | Y 2008 | ||||||
| NEKTAR THERAPEUTICS (NKTR) | 2/25/2009 12:00:00 AM | View | Financials | Earnings | SEC | Y 2008 | Export Earnings Model |